d8afb1494ce2de5dd87bc35483558d22

PSA ANTÍGENO ESPECÍFICO DE PRÓSTATA. PRUEBA RÁPIDA EN SANGRE TOTAL/SUERO/PLASMA

PSA PROSTATE-SPECIFIC ANTIGEN. RAPID WHOLE BLOOD/SERUM/PLASMA TEST
BIOLORE LTDA·II·Colombia INVIMA·Expires October 03, 2032
Device classification
Risk class / Clase de Riesgo
II
Product type (Spanish)
REACTIVO DIAGNOSTICO
Product type (English)
DIAGNOSTIC REAGENT
Registration information
Analysis ID
d8afb1494ce2de5dd87bc35483558d22
Expire date
October 03, 2032
Authorized company / Fabricante
Name (Spanish)
BIOLORE LTDA
Name (English)
BIOLORE LTDA
Product use / Uso del Producto
Spanish

DETERMINACIÓN DE LOS DIFERENTES ANALITOS _x000D_ RELACIONADOS CON MUESTRAS PROCEDENTES DEL _x000D_ ORGANISMO HUMANO_x000D_

English

DETERMINATION OF THE DIFFERENT ANALYTES _x000D_ RELATED TO SAMPLES FROM THE _x000D_ ORGANISM HUMANO_x000D_

About this record

Access comprehensive regulatory information for PSA ANTÍGENO ESPECÍFICO DE PRÓSTATA. PRUEBA RÁPIDA EN SANGRE TOTAL/SUERO/PLASMA (PSA PROSTATE-SPECIFIC ANTIGEN. RAPID WHOLE BLOOD/SERUM/PLASMA TEST ) in the Colombia medical device market through Pure Global AI's free database. This II medical device is registered under INVIMA analysis ID d8afb1494ce2de5dd87bc35483558d22 and manufactured by BIOLORE LTDA. The device was registered on October 03, 2032.

This page provides complete registration details including product type (DIAGNOSTIC REAGENT), authorised information, and regulatory compliance data from the official Colombia INVIMA medical device database. Pure Global AI offers free access to Colombia's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate INVIMA regulations efficiently.